sentinext therapeutics
Sentinext Secures US$14 Million For HFMD Vaccine
Sentinext’s latest round of funding will see the development of their hand, foot and mouth disease vaccine to Phase I clinical trials.
Sentinext’s latest round of funding will see the development of their hand, foot and mouth disease vaccine to Phase I clinical trials.
